EGFR and breast cancer: Overall, the results of this study indicate a prognostic value of S-EGFR and S-HBEGF in early-stage breast cancer and could be a stepping stone for further investigation of S-EGFR and S-HBEGF as prognostic biomarkers in breast cancer.